Investigation of metabolic and circulatory parameters that predict effects of dapagliflozin, a sodium-glucose cotransporter 2 inhibitor, on blood glucose and body weight in a retrospective, multicenter study

o1892

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

https://fukuoka-u.repo.nii.ac.jp/record/5284/files/o1892.pdf

内容の要旨及び結果の要旨

application/pdf

ファイル	ライセンス
o1892.pdf (435.9 kB) sha256 fed67dfe341823aa44f6dd2ddfcd21f3a7ac252e73ea3c4e454cadb2a340ea13

Version	Date Modified	Object File Name	File Size	File Hash Value	Contributor Name	Show/Hide

Downloads

Plays